Gilead Sciences Inc (NASDAQ: GILD)

DRUGS - Biotechnology

Health Care

Stock price data as of

Closing price: $110.08
  • Support level
    $98.63
  • Resistance level
    $111.39
  • Beta
    0.4
  • RSI (14-day)
    70.5
  • With a 72.2 percent return in the past year, this stock outperformed 90 percent of stocks in the S&P-100.
  • Up 3.1 percent, GILD is one of this week's biggest gainers.
  • Volatility is forecast to fall over the next month.
  • With RSI > 70, GILD is overbought. Odds slightly favor a short-term price reversal.
52-week range
52-week low 52-week high Price as % of range
$63.15 $117.41 89.6%
Moving averages
200 day 50 day 20 day 10 day
$95.35 $105.64 $104.03 $107.83

Value at risk (VaR)

There is an estimated 5% probability that the stock price will fall by more than VaR in time period.

  • In the next week
    9.1%
  • In the next month
    16.7%
  • In the next year
    51.5%
Volatility estimates (annualized standard deviations)
Period Value
Historical (5 year) 24.4%
Last month 28.4%
Current estimate 33.5%
Next month forecast 29.6%